Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Transplant Cell Ther. 2022 Feb 14;28(5):250.e1–250.e8. doi: 10.1016/j.jtct.2022.02.008

Figure 1.

Figure 1.

Phenotypic analyses of NK cell products manufactured from 3 donors. (A) Presented as percentages are the T cell, NK cell, and B cell content of PBMCs obtained from donor leukapheresis (precolumn), CD3-depleted PBMCs at start of cell culture (starter material), and final NK cell product harvested after 2 to 3 weeks of culture. (B) NK cell products were analyzed for retention of various functional receptors at thaw following cryopreservation (frozen) compared with the same products when harvested from culture (fresh). The observed difference in CD16+ cell population was statistically significant. *P = .029. Values shown are percentages.